Comprehensive bioinformatics analysis identified HMGB3 as a promising immunotherapy target for glioblastoma multiforme
HMGB3 as a heterogeneous and immunosuppressive molecule in the GBM TME, making it a potential target for precision therapy for GBM.
Authors
- Qinghua Zhang (ORCID: https://orcid.org/0000-0002-6416-9134)
- Peizhi Xu
- Xinglong Li (ORCID: https://orcid.org/0000-0003-1656-7370)
- Libin Wang (ORCID: https://orcid.org/0000-0001-7422-0290)
Institutions
- Shenzhen Sixth People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1007/s12672-025-02235-6
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52